Qiagen Pays $28.5M Cash For Molecular Staging Technology Sep. 29, 2004 By Cormac Sheridan Qiagen NV is paying $28.5 million in cash to acquire whole-genome amplification technology from Molecular Staging Inc. (BioWorld International)Read More
RSS